BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14558483)

  • 1. [Depression in patients with Parkinson's disease].
    Sławek J; Derejko M; Lass P
    Neurol Neurochir Pol; 2003; 37(2):351-64. PubMed ID: 14558483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression and dementia: the most frequent non-motor symptoms of Parkinson disease].
    Sławek J; Derejko M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():103-15. PubMed ID: 15098337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
    Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
    Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
    Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
    J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences.
    Schrag A; Hovris A; Morley D; Quinn N; Jahanshahi M
    Mov Disord; 2003 Nov; 18(11):1250-6. PubMed ID: 14639664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
    Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.
    Phu AL; Xu Z; Brakoulias V; Mahant N; Fung VS; Moore GD; Martin A; Starcevic V; Krause M
    J Clin Neurosci; 2014 Jan; 21(1):63-6. PubMed ID: 24035421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
    Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of depression on motor function and disease severity of Parkinson's disease.
    Papapetropoulos S; Ellul J; Argyriou AA; Chroni E; Lekka NP
    Clin Neurol Neurosurg; 2006 Jul; 108(5):465-9. PubMed ID: 16150537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in Polish patients with long-lasting Parkinson's disease.
    Zach M; Friedman A; Sławek J; Derejko M
    Mov Disord; 2004 Jun; 19(6):667-72. PubMed ID: 15197705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
    Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
    JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depression and Parkinson disease].
    Errea JM; Ara JR
    Rev Neurol; 1999 Apr 1-15; 28(7):694-8. PubMed ID: 10363296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.